These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36688795)

  • 1. Long-term follow-up of an IgA nephropathy cohort: outcomes and risk factors.
    Gadola L; Cabrera MJ; Garau M; Coitiño R; Aunchayna MH; Noboa O; Alvarez MA; Balardini S; Desiderio G; Dibello N; Ferreiro A; Giró S; Luzardo L; Maino A; Orihuela L; Ottati MG; Urrestarazú A
    Ren Fail; 2023 Dec; 45(1):2152694. PubMed ID: 36688795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy.
    Bobart SA; Alexander MP; Shawwa K; Vaughan LE; Ghamrawi R; Sethi S; Cornell L; Glassock RJ; Fervenza FC; Zand L
    Nephrol Dial Transplant; 2021 Apr; 36(5):840-847. PubMed ID: 31859353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Cyclophosphamide and Glucocorticoid Therapy in IgA Nephropathy: A Single-Center Retrospective Analysis.
    Beck N; Walz G; Schneider J
    Kidney360; 2022 Mar; 3(3):506-515. PubMed ID: 35582170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
    Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
    J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Significance of Crescents on the Clinical Features and Outcomes of Primary Immunoglobin A Nephropathy.
    Du Y; Chen S; Wang F; Zhang P; Liu M; Liu C; Zhong X; Qin J; Li G; Wang W
    Front Med (Lausanne); 2022; 9():864667. PubMed ID: 35847826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria.
    Pei G; Tan J; Tang Y; Tan L; Zhong Z; Zhou L; Chen C; Qin W
    Medicine (Baltimore); 2020 Jun; 99(24):e20513. PubMed ID: 32541473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics, risk factors and renal outcome in IgA nephropathy with crescents.
    Ruan Y; Hong F; Wu J; Lin M; Wang C; Lian F; Cao F; Yang G; Huang L; Huang Q
    J Nephrol; 2022 May; 35(4):1113-1121. PubMed ID: 35290652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course of Immunoglobulin A nephropathy with crescents in a multi-ethnic Southeast Asian cohort.
    Lim CC; Baikunje S; Choo JCJ; Tan PH; Foo M; Woo KT
    Nephrology (Carlton); 2020 Sep; 25(9):708-713. PubMed ID: 32400945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
    Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
    Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.
    Tsushima H; Samejima KI; Eriguchi M; Uemura T; Tasaki H; Fukata F; Nishimoto M; Kosugi T; Tanabe K; Okamoto K; Matsui M; Tsuruya K
    Clin Exp Nephrol; 2022 Aug; 26(8):797-807. PubMed ID: 35426595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
    Chen MG; Ye XH; Liang HY; Yang Q
    Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):610-3. PubMed ID: 27510875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Added Value of Crescents on Oxford Classification Score in Risk Stratification of End-stage Kidney Disease in Patients with IgA Nephropathy.
    Ossareh S; Nazemzadeh N; Asgari M; Bagherzadegan H; Afghahi H
    Iran J Kidney Dis; 2022 Mar; 16(2):115-124. PubMed ID: 35489080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
    Terinte-Balcan G; Stancu S; Zugravu A; Capusa C; Radu A; Mircescu G; Stefan G
    J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin A Deposits In Renal Allografts: A Prospective Longitudinal Single-Center Study.
    Ganesh K; Jayaram JK; Thomas RM; Abraham TT; Kumar JS; Simon SS; Abraham MA
    Transplant Proc; 2024; 56(1):97-104. PubMed ID: 38216361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of IgA nephropathy patients with different proportions of crescents.
    Zhang W; Zhou Q; Hong L; Chen W; Yang S; Yang Q; Chen W; Yu X
    Medicine (Baltimore); 2017 Mar; 96(11):e6190. PubMed ID: 28296731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.